Naminterol

This classification denotes a beta-adrenergic agonist with the molecular formula C19H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q13LFM3WG, chemically known as 5-amino-alpha-(((p-methoxy-alpha-methylphenethyl)amino)methyl)-m-xylene-alpha,alpha-diol but generally known as naminterol, which bears US NIH Compound Identifier 174101. European Medicines Agency schedules Naminterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09144MIG. The term NAMINTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). NAMINTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naminterol under HS 29225000 and SITC 51467. As of Q4 2014, NAMINTEROL remains the US FDA Preferred Term for this commodity. Naminterol bears US NLM identifiers UMLS ID C2827270 and NCI Concept Code C83980. SMILES: OC(CNC(CC1CCC(OC)CC1)C)C1CC(CC(N)C1)CO.